| Literature DB >> 8900239 |
G Tromp1, H Kuivaniemi, S Raphael, L Ala-Kokko, A Christiano, E Considine, R Dhulipala, J Hyland, A Jokinen, S Kivirikko, R Korn, S Madhatheri, S McCarron, L Pulkkinen, H Punnett, K Shimoya, L Spotila, A Tate, C J Williams.
Abstract
Blau syndrome (MIM 186580), first described in a large, three-generation kindred, is an autosomal, dominantly inherited disease characterized by multiorgan, tissue-specific inflammation. Its clinical phenotype includes granulomatous arthritis, skin rash, and uveitis and probably represents a subtype of a group of clinical entities referred to as "familial granulomatosis." It is the sole human model with recognizably Mendelian inheritance for a variety of multisystem inflammatory diseases affecting a significant percentage of the population. A genomewide search for the Blau susceptibility locus was undertaken after karyotypic analysis revealed no abnormalities. Sixty-two of the 74-member pedigree were genotyped with dinucleotide-repeat markers. Linkage analysis was performed under a dominant model of inheritance with reduced penetrance. The marker D16S298 gave a maximum LOD score of 3.75 at theta = .04, with two-point analysis. LOD scores for flanking markers were consistent and placed the Blau susceptibility locus within the 16p12-q21 interval.Entities:
Mesh:
Year: 1996 PMID: 8900239 PMCID: PMC1914842
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025